Abcam plc
Abcam Limited, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and vario… Read more
Abcam plc (ABCZF) - Total Liabilities
Latest total liabilities as of June 2023: $307.90 Million USD
Based on the latest financial reports, Abcam plc (ABCZF) has total liabilities worth $307.90 Million USD as of June 2023.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Abcam plc - Total Liabilities Trend (2002–2022)
This chart illustrates how Abcam plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Abcam plc Competitors by Total Liabilities
The table below lists competitors of Abcam plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bim Birlesik Magazalar
PINK:BMBRF
|
USA | $168.01 Billion |
|
Riot Blockchain Inc
NASDAQ:RIOT
|
USA | $974.07 Million |
|
Sensata Technologies Holding NV
NYSE:ST
|
USA | $4.35 Billion |
|
RLI Corp
NYSE:RLI
|
USA | $4.38 Billion |
|
Gamuda Bhd
KLSE:5398
|
Malaysia | RM19.69 Billion |
|
Knorr-Bremse Aktiengesellschaft
PINK:KNBHF
|
USA | $5.68 Billion |
|
Shenzhou International Group Holdings Limited
PINK:SHZHY
|
USA | $19.22 Billion |
|
Hongda
SHG:600331
|
China | CN¥2.10 Billion |
Liability Composition Analysis (2002–2022)
This chart breaks down Abcam plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.43 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.30 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Abcam plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Abcam plc (2002–2022)
The table below shows the annual total liabilities of Abcam plc from 2002 to 2022.
| Year | Total Liabilities | Change |
|---|---|---|
| 2022-12-31 | $329.70 Million | -0.09% |
| 2021-12-31 | $330.00 Million | +6.87% |
| 2019-12-31 | $308.80 Million | +398.87% |
| 2018-12-31 | $61.90 Million | -1.90% |
| 2017-12-31 | $63.10 Million | +15.62% |
| 2016-12-31 | $54.58 Million | -20.18% |
| 2015-12-31 | $68.37 Million | +90.76% |
| 2014-12-31 | $35.84 Million | +39.50% |
| 2013-12-31 | $25.69 Million | -13.31% |
| 2012-12-31 | $29.64 Million | +7.59% |
| 2011-12-31 | $27.55 Million | +118.53% |
| 2010-12-31 | $12.61 Million | +22.53% |
| 2009-12-31 | $10.29 Million | +18.98% |
| 2008-12-31 | $8.65 Million | +75.24% |
| 2007-12-31 | $4.93 Million | +25.19% |
| 2006-12-31 | $3.94 Million | +26.83% |
| 2005-12-31 | $3.11 Million | +39.43% |
| 2004-12-31 | $2.23 Million | +84.98% |
| 2003-12-31 | $1.21 Million | +185.55% |
| 2002-12-31 | $422.00K | -- |